Rheonix Inc. announced that data demonstrating the utility of the Rheonix CARD (Chemistry And Reagent Device) system for human in vitro diagnostic purposes will be presented in poster sessions at the American Association for Clinical Chemistry Annual Meeting being held in Anaheim, CA, July 25-29, 2010. Rheonix is also exhibiting at the Clinical Lab Expo.

The Rheonix CARD system is designed to meet the need for simple instrumentation that can perform a broad range of new or existing molecular diagnostic assays. Rheonix technology incorporates disposable microfluidic chip technology and a scalable automated platform to analyze single or multiple clinical raw samples, providing multiplexed endpoint analysis for a wide breadth of diagnostic applications.

Rheonix Presentations at AACC:

Wednesday, July 28, 2:00 PM - 4:30 PM Pacific Time

-Session 14, Presentation number D-09, “Fully Integrated, Automatic, and Rapid Molecular Detection and Identification of 20 Clinically Relevant HPV types using the CARD Platform”

-Session 14, Presentation number D-10, “CARD Technology for Rapid and Automatic Determination of SNP Profile for Pharmacogenomics”

Thursday, July 29, 9:00 AM - 12:00 PM Pacific Time

-Session 20, Presentation number E-05, “Rapid Molecular Detection of Sexually Transmitted Infections using a fully automated, microfluidic CARD”